Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

NetraMark Holdings Inc (AIAI)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
0.34 0.00    0.00%
07/05 - Closed. Currency in CAD ( Disclaimer )
Type:  Equity
Market:  Canada
  • Volume: 0
  • Bid/Ask: 0.00 / 0.34
  • Day's Range: 0.30 - 0.37
NetraMark Holdings 0.34 0.00 0.00%

NetraMark Holdings Inc Company Profile

 
Get an in-depth profile of NetraMark Holdings Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustrySoftware & IT Services
SectorTechnology
Employees

-

Equity Type

ORD

NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada. Its products suite comprises NetraAI, an interactive augmented intelligence platform; Netra Shatter; and Netra Health Atlas. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.

Contact Information

Address 1655 Dupont Street Suite 101
Toronto, M6P 3T1
Canada
Phone 403-681-2549
Fax -
Web www.netramark.com

Top Executives

Name Age Since Title
MaryAnne Rizk - 2023 Member of Strategic Advisory Board
Peter Carlisle - - Member of Advisory Board
Andrew Parks - 2021 Independent Director
Larry Alphs - 2023 Chief Medical Officer & Member of Advisory Board
Dean Sebastian - - Member of Advisory Board
Dhananja Jayalath - 2022 Member of Advisory Board
Douglas James Cook - 2022 Member of Advisory Board
William Travis - - Member of Advisory Board
Chuck McBride - - Member of Advisory Board
Amal Wolfe - - Member of Advisory Board
Gino DeMichele 54 2022 Independent Director
Abhishek Agrawal - 2023 Member of Advisory Board
Kevin Robert Taylor 55 2021 Independent Chairman of the Board
Daniel Gallucci 47 2020 Founder, Chief Performance Officer & Director
Sheetal Jaitly 42 2021 Independent Director
Joseph Geraci - 2021 Founder, Chief Scientific & Technical Officer and Director
Jeff Huntsman - 2024 Strategic Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

AIAI Comments

Write your thoughts about NetraMark Holdings Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mike Powell
Mike Powell Feb 16, 2022 1:23PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
NetraAI (full subsidiary of MEND) is being leveraged to lead the discovery phase of the research process in a joint-effort between Cyclica and Nurosene to accelerate novel drug discovery for neurodegenerative diseases. Tapping into a ~US$40B market.
Reply
0 0
Report
Henry Wong
Henry Wong Feb 14, 2022 1:07PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Nurosene Health recently announced a partnership with Cyclica, leveraging their acquisition with NetraMark. NetraAI will be used to lead the discovery phase of the research process in a joint-effort plan accelerating drug discovery for neurodegenerative diseases - this market is valued at US$40B. This is significant news and follows $MNNDF’s breakout week.
Reply
0 0
Report
Henry Wong
Henry Wong Jan 06, 2022 2:33PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
2021 was a huge year for Nurosene, the mHealth company tapping into the massive $300B+ market and backed by a AAA roster of major celebrity endorsers. In October ‘21, $MEND closed the acquisition of the AI-driven pharmatech company Netramark for C$15M. Solid opportunity to learn more about their promising 2022 pipeline at the upcoming H.C. Wainwright Bioconnect Virtual Investor conference on January 10-13, 2022 - search the event on google for free registration.
Reply
0 0
Report
Henry Wong
Henry Wong Dec 31, 2021 1:19PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What’s your point of entry? Q4 was huge for Nurosene, hitting all-time highs in November with a promise of much more with mHealth opportunities tapping into the massive $300B+ market. Definitely one to keep your eye on going into 2022, this blog has solid analysis from a portfolio manager with key insights into Nurosene’s 4-pronged approach generating revenues. Article titled 'Keep your eye on Nurosene Health, this portfolio manager says' on Cantechletter '
Reply
0 0
Report
Henry Wong
Henry Wong Nov 24, 2021 4:12PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What's your point of entry? Tons of 'very bullish' ratings being called on the fresh-to-scene mHealth app, Nurosene. With a significant roster of celebrity endorsers and plenty media coverage, this shouldn't be a sleeper for long. They've hit all-time highs this week showing no upper chart resistance and are riding the mHealth rise tapping into the massive $300B+ market to grow in.
Reply
0 0
Report
Jeremy Lin
Jeremy Lin Nov 18, 2021 6:59PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Good to hear that Dr. Geraci is presenting at ISCTM's 18th Annual Scientific Meeting about the use of machine learning and AI in drug development. The last month has been great for $MEND. Nick Jonas’s investment and a new president of Netramark will help grow both the app and their AI business. Upwards momentum should push this above $2 soon.
Reply
0 0
Report
Henry Wong
Henry Wong Nov 16, 2021 1:56PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$MEND has been on the up, the AI-driven wellness company has been making a splash with a bevvy of high-profile celebrity endorsers and investors. Including Nick Jonas and NFL and NHL players. $MEND.c CEO, Ranj Bath will be presenting at the 3rd Annual Health & Wellness conference today. You can still register online for free, just search Nurosene to Present at the Canaccord Genuity 3rd Annual Health & Wellness Virtual Conference
Reply
0 0
Report
Jeremy Lin
Jeremy Lin Nov 12, 2021 3:13PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
About 33% of people report feeling extreme stress, 77% experience stress that affects their physical health, 73% have stress that impacts their mental health, and 48% have trouble sleeping because of stress. Accessibility and affordability are why mobile health will become a $300B+ market soon, and $MEND.CN is ready to become a leader in the space.
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email